{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:39:26Z","timestamp":1791589166389,"version":"4.3.4"},"reference-count":230,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Cytomegalovirus (CMV) infection is a significant clinical concern in newborns, immunocompromised patients with acquired immunodeficiency syndrome (AIDS), and patients undergoing immunosuppressive therapy or chemotherapy. CMV infection affects many organs, such as the lungs, digestive organs, the central nerve system, and eyes. In addition, CMV infection sometimes occurs in immunocompetent individuals. CMV ocular diseases includes retinitis, corneal endotheliitis, and iridocyclitis. CMV retinitis often develops in infected newborns and immunocompromised patients. CMV corneal endotheliitis and iridocyclitis sometimes develop in immunocompetent individuals. Systemic infections and CMV ocular diseases often require systemic treatment in addition to topical treatment.<\/jats:p>","DOI":"10.3390\/v16071110","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T11:30:55Z","timestamp":1720697455000},"page":"1110","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Overview of Cytomegalovirus Ocular Diseases: Retinitis, Corneal Endotheliitis, and Iridocyclitis"],"prefix":"10.3390","volume":"16","author":[{"given":"Reiko","family":"Kobayashi","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8241-5378","authenticated-orcid":false,"given":"Noriyasu","family":"Hashida","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0039-6257(93)90064-E","article-title":"Systemic viral infections and their retinal and choroidal manifestations","volume":"37","author":"Yoser","year":"1993","journal-title":"Surv. Ophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1056\/NEJM199409083311005","article-title":"Owl\u2019s-Eye Cells","volume":"331","author":"Eagle","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_3","unstructured":"Knipe, D.M., and Howley, P.M. (2013). Cyotmegaloviruses. Fields Virology, Lippencott Williams and Wilkins. [6th ed.]."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1093\/cid\/cit629","article-title":"Congenital cytomegalovirus infection: Clinical outcome","volume":"57","author":"Boppana","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jpeds.2013.12.007","article-title":"Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection","volume":"164","author":"Dreher","year":"2014","journal-title":"J. Pediatr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/j.spid.2004.09.011","article-title":"Congenital cytomegalovirus infection: Outcome and diagnosis","volume":"16","author":"Ross","year":"2005","journal-title":"Semin. Pediatr. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.00062-12","article-title":"The \u201csilent\u201d global burden of congenital cytomegalovirus","volume":"26","author":"Manicklal","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/GCO.0b013e328342f1f6","article-title":"Cytomegalovirus infections during pregnancy","volume":"23","author":"Nigro","year":"2011","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/1568005310101020179","article-title":"Cytomegalovirus infection in immunocompetent and immunocompromised individuals\u2014A review","volume":"1","author":"Vancikova","year":"2001","journal-title":"Curr. Drug Targets Immune Endocr. Metabol. Disord."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00006454-199202000-00007","article-title":"Symptomatic congenital cytomegalovirus infection: Neonatal morbidity and mortality","volume":"11","author":"Boppana","year":"1992","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-1111-1_1","article-title":"Overview of Human Cytomegalovirus Pathogenesis","volume":"2244","author":"HFulkerson","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/path.4437","article-title":"The pathogenesis of human cytomegalovirus","volume":"235","author":"Griffiths","year":"2015","journal-title":"J. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev. Med. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1473-3099(04)01202-2","article-title":"Human cytomegalovirus: Clinical aspects, immune regulation, and emerging treatments","volume":"4","author":"Gandhi","year":"2004","journal-title":"Lancet Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1743-422X-5-47","article-title":"Severe cytomegalovirus infection in apparently immunocompetent patients: A systematic review","volume":"5","author":"Rafailidis","year":"2008","journal-title":"Virol. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/01.TP.0000040601.60276.96","article-title":"Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients","volume":"75","author":"Drew","year":"2003","journal-title":"Transplantation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00002030-200003310-00007","article-title":"Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients","volume":"14","author":"Fillet","year":"2000","journal-title":"AIDS"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ophtha.2007.04.053","article-title":"Cytomegalovirus as an Etiologic Factor in Corneal Endotheliitis","volume":"115","author":"Koizumi","year":"2008","journal-title":"Ophthalmology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1136\/bjophthalmol-2014-306432","article-title":"Aflibercept therapy for polypoidal choroidal vasculopathy: Short-term results of a multicentre study","volume":"99","author":"Koizumi","year":"2015","journal-title":"Br. J. Ophthalmol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Ye, Z., Yang, Y., Ke, W., Li, Y., Wang, K., and Chen, M. (2023). Overview and update on cytomegalovirus-associated anterior uveitis and glaucoma. Front. Public Health, 11.","DOI":"10.3389\/fpubh.2023.1117412"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.1073\/pnas.81.19.6134","article-title":"Cytomegalovirus infects human lymphocytes and monocytes: Virus expression is restricted to immediate-early gene products","volume":"81","author":"Rice","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","first-page":"63","article-title":"Cytomegalovirus cell tropism","volume":"325","author":"Sinzger","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"16352","DOI":"10.1038\/s41598-019-52906-y","article-title":"Distribution of the CMV glycoprotein gH\/gL\/gO and gH\/gL\/pUL128\/pUL130\/pUL131A complex variants and associated clinical manifestations in infants infected congenitally or postnatally","volume":"9","author":"Paradowska","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Alston, C.I., and Dix, R.D. (2019). SOCS and Herpesviruses, with Emphasis on Cytomegalovirus Retinitis. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00732"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1073\/pnas.95.7.3937","article-title":"Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells","volume":"95","author":"Hahn","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"7543","DOI":"10.1128\/JVI.75.16.7543-7554.2001","article-title":"Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent","volume":"75","author":"Streblow","year":"2001","journal-title":"J. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature04946","article-title":"Intracellular pattern recognition receptors in the host response","volume":"442","author":"Meylan","year":"2006","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1172\/JCI110672","article-title":"Spontaneous activation of latent cytomegalovirus from murine spleen explants. Role of lymphocytes and macrophages in release and replication of virus","volume":"70","author":"Jordan","year":"1982","journal-title":"J. Clin. Investig."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1128\/jvi.68.10.6243-6253.1994","article-title":"Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus","volume":"68","author":"Stoddart","year":"1994","journal-title":"J. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.1128\/JVI.73.7.5970-5980.1999","article-title":"Replication of murine cytomegalovirus in differentiated macrophages as a determinant of viral pathogenesis","volume":"73","author":"Hanson","year":"1999","journal-title":"J. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"10286","DOI":"10.1128\/JVI.00373-11","article-title":"Reversible inhibition of murine cytomegalovirus replication by gamma interferon (IFN-gamma) in primary macrophages involves a primed type I IFN-signaling subnetwork for full establishment of an immediate-early antiviral state","volume":"85","author":"Kropp","year":"2011","journal-title":"J. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1002\/eji.201545495","article-title":"Molecular characterization of HCMV-specific immune responses: Parallels between CD8(+) T cells, CD4(+) T cells, and NK cells","volume":"45","author":"Hertoghs","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3109\/02713689408999892","article-title":"Mice immunosuppressed by murine retrovirus infection (MAIDS) are susceptible to cytomegalovirus retinitis","volume":"13","author":"Dix","year":"1994","journal-title":"Curr. Eye Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1084\/jem.173.5.1053","article-title":"Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function","volume":"173","author":"Welsh","year":"1991","journal-title":"J. Exp. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0092-8674(02)00701-8","article-title":"Cytokine signaling in 2002: New surprises in the Jak\/Stat pathway","volume":"109","author":"Gadina","year":"2002","journal-title":"Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nri2093","article-title":"SOCS proteins, cytokine signalling and immune regulation","volume":"7","author":"Yoshimura","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1128\/JVI.01857-10","article-title":"Viral exploitation of host SOCS protein functions","volume":"85","author":"Akhtar","year":"2011","journal-title":"J. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"10800","DOI":"10.1073\/pnas.96.19.10800","article-title":"Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression","volume":"96","author":"Dickensheets","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.4049\/jimmunol.163.5.2640","article-title":"Lipopolysaccharide induces in macrophages the synthesis of the suppressor of cytokine signaling 3 and suppresses signal transduction in response to the activating factor IFN-gamma","volume":"163","author":"Stoiber","year":"1999","journal-title":"J. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1074-7613(03)00240-1","article-title":"Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity","volume":"19","author":"Hanada","year":"2003","journal-title":"Immunity"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1074-7613(03)00243-7","article-title":"Defining control: Regulation of dendritic cell activation and immune homeostasis by SOCS1","volume":"19","author":"Starr","year":"2003","journal-title":"Immunity"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.4049\/jimmunol.166.4.2260","article-title":"IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: Involvement of the suppressors of cytokine signaling-1 protein","volume":"166","author":"Nguyen","year":"2001","journal-title":"J. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1189\/jlb.0306209","article-title":"Molecular mechanisms involved in interleukin-4-induced human neutrophils: Expression and regulation of suppressor of cytokine signaling","volume":"81","author":"Pelletier","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.celrep.2016.03.035","article-title":"H3K4me3 demethylase Kdm5a is required for NK cell activation by associating with p50 to suppress SOCS1","volume":"15","author":"Zhao","year":"2016","journal-title":"Cell Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.4049\/jimmunol.168.7.3181","article-title":"Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: Implications for Th cell lineage commitment and maintenance","volume":"168","author":"Egwuagu","year":"2002","journal-title":"J. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.biocel.2005.04.005","article-title":"The role of suppressors of cytokine signalling in thymopoiesis and T cell activation","volume":"37","author":"Fletcher","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.2337\/db07-1761","article-title":"Suppressors of cytokine-signaling proteins induce insulin resistance in the retina and promote survival of retinal cells","volume":"57","author":"Liu","year":"2008","journal-title":"Diabetes"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1073\/pnas.111163898","article-title":"Biologic consequences of Stat1-independent IFN signaling","volume":"98","author":"Gil","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0092-8674(00)80047-1","article-title":"SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine","volume":"98","author":"Alexander","year":"1999","journal-title":"Cell"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1074-7613(00)00078-9","article-title":"Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1","volume":"13","author":"Diehl","year":"2000","journal-title":"Immunity"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1074-7613(02)00446-6","article-title":"SOCS1\/JAB is a negative regulator of LPS-induced macrophage activation","volume":"17","author":"Kinjyo","year":"2002","journal-title":"Immunity"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.it.2009.07.001","article-title":"SOCS1 and SOCS3 in the control of CNS immunity","volume":"30","author":"Baker","year":"2009","journal-title":"Trends Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/ni931","article-title":"SOCS3 negatively regulates IL-6 signaling in vivo","volume":"4","author":"Croker","year":"2003","journal-title":"Nat. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1084\/jem.20090545","article-title":"Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis","volume":"206","author":"Taleb","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.tcb.2003.10.009","article-title":"Receptors and immune sensors: The complex entry path of human cytomegalovirus","volume":"14","author":"Compton","year":"2004","journal-title":"Trends Cell Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1086\/367900","article-title":"Inter- and intragenic variations complicate the molecular epidemiology of human cytomegalovirus","volume":"187","author":"Rasmussen","year":"2003","journal-title":"J. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Nguyen, C.C., and Kamil, J.P. (2018). Pathogen at the Gates: Human Cytomegalovirus Entry and Cell Tropism. Viruses, 10.","DOI":"10.20944\/preprints201811.0378.v2"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.coviro.2012.01.001","article-title":"Human cytomegalovirus entry into cells","volume":"2","author":"Vanarsdall","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1099\/0022-1317-74-2-255","article-title":"Structure, composition and heparin binding properties of a human cytomegalovirus glycoprotein complex designated gC-II","volume":"74","author":"Kari","year":"1993","journal-title":"J. Gen. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1006\/viro.1993.1192","article-title":"Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate","volume":"193","author":"Compton","year":"1993","journal-title":"Virology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"15470","DOI":"10.1073\/pnas.0406821101","article-title":"Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain","volume":"101","author":"Feire","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nm1236","article-title":"Integrin alphavbeta3 is a coreceptor for human cytomegalovirus","volume":"11","author":"Wang","year":"2005","journal-title":"Nat. Med."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Burke, H.G., and Heldwein, E.E. (2015). Crystal Structure of the Human Cytomegalovirus Glycoprotein B. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1005300"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"10026","DOI":"10.1128\/JVI.00710-10","article-title":"The glycoprotein B disintegrin-like domain binds beta 1 integrin to mediate cytomegalovirus entry","volume":"84","author":"Feire","year":"2010","journal-title":"J. Virol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1128\/JVI.02748-06","article-title":"Developmental regulation of human cytomegalovirus receptors in cytotrophoblasts correlates with distinct replication sites in the placenta","volume":"81","author":"Maidji","year":"2007","journal-title":"J. Virol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"10960","DOI":"10.1128\/JVI.78.20.10960-10966.2004","article-title":"Identification of proteins in human cytomegalovirus (HCMV) particles: The HCMV proteome","volume":"78","author":"Varnum","year":"2004","journal-title":"J. Virol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1128\/JVI.01251-08","article-title":"Human cytomegalovirus glycoprotein B is required for virus entry and cell-to-cell spread but not for virion attachment, assembly, or egress","volume":"83","author":"Isaacson","year":"2009","journal-title":"J. Virol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/rmv.438","article-title":"Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains","volume":"14","author":"Pignatelli","year":"2004","journal-title":"Rev. Med. Virol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"11881","DOI":"10.1128\/JVI.74.24.11881-11892.2000","article-title":"Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73)","volume":"74","author":"Mach","year":"2000","journal-title":"J. Virol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1099\/vir.0.010967-0","article-title":"Glycoprotein N subtypes of human cytomegalovirus induce a strain-specific antibody response during natural infection","volume":"90","author":"Burkhardt","year":"2009","journal-title":"J. Gen. Virol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Arun, K., Michael, F., and Ravit, A.-B. (2014). Activation of nucleotide oligomerization domain (NOD) 2 by human cytomegalovirus initiates innate immune responses and restricts virus replication. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0092704"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Oliveira-Nascimento, L., Massari, P., and Wetzler, L.M. (2012). The Role of TLR2 in Infection and Immunity. Front. Immunol., 3.","DOI":"10.3389\/fimmu.2012.00079"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Igor, L., Pelton, C., Streblow, D., DeFilippis, V., McWeeney, S., and Nelson, J.A. (2015). Human Cytomegalovirus miR-UL112-3p Targets TLR2 and Modulates the TLR2\/IRAK1\/NF\u03baB Signaling Pathway. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1004881"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.4049\/jimmunol.177.10.7094","article-title":"Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells","volume":"177","author":"Mario","year":"2006","journal-title":"J. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1128\/JVI.77.8.4588-4596.2003","article-title":"Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2","volume":"77","author":"Compton","year":"2003","journal-title":"J. Virol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Gerna, G., Kabanova, A., and Lilleri, D. (2019). Human Cytomegalovirus Cell Tropism and Host Cell Receptors. Vaccines, 7.","DOI":"10.3390\/vaccines7030070"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Liu, J., Jardetzky, T.S., Chin, A.L., Johnson, D.C., and Vanarsdall, A.L. (2018). The human cytomegalovirus penetrates hosttrimer and Pentamer promote sequential steps in entry into epithelial and endothelial cells by pH-independent fusion at the cell surfaces and endosomes. J. Virol., 92.","DOI":"10.1128\/JVI.01336-18"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S1386-6532(02)00098-7","article-title":"Expression and reconstitution of the gH\/gL\/gO complex of human cytomegalovirus","volume":"25","author":"Kinzler","year":"2002","journal-title":"J. Clin. Virol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/JVI.80.2.710-722.2006","article-title":"Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion","volume":"80","author":"Ryckman","year":"2006","journal-title":"J. Virol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.cell.2018.06.028","article-title":"An unbiased screen for human cytomegalovirus identifies neuropilin-2 as a central viral receptor","volume":"174","author":"Marcandalli","year":"2018","journal-title":"Cell"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e00781-18","DOI":"10.1128\/mBio.00781-18","article-title":"CD147 Promotes Entry of Pentamer-Expressing Human Cytomegalovirus into Epithelial and Endothelial Cells","volume":"9","author":"Liu","year":"2018","journal-title":"mBio"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1128\/JVI.01748-09","article-title":"Human cytomegalovirus induces the interferon response via the DNA sensor ZBP1","volume":"84","author":"DeFilippis","year":"2010","journal-title":"J. Virol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.4049\/jimmunol.0900557","article-title":"The nucleotide-binding oligomerization domain-like receptor NLRC5 is involved in IFN-dependent antiviral immune responses","volume":"184","author":"Kuenzel","year":"2010","journal-title":"J. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"(2007). Kanneganti TD, Lamkanfi M, Nunez G Intracellular NOD-like receptors in host defense and disease. Immunity, 27, 549\u2013559.","DOI":"10.1016\/j.immuni.2007.10.002"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"(2008). Shaw MH, Reimer T, Kim YG, Nunez G NOD-like receptors (NLRs): Bona fide intracellular microbial sensors. Curr. Opin. Immunol., 20, 377\u2013382.","DOI":"10.1016\/j.coi.2008.06.001"},{"key":"ref_86","first-page":"251","article-title":"Epstein-Barr virus, cytomegalovirus, and infectious mononucleosis","volume":"21","author":"Bravender","year":"2010","journal-title":"Adolesc. Med. State Art. Rev."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.idcr.2017.10.008","article-title":"Primary cytomegalovirus infection in immunocompetent adults in the United States\u2014A case series","volume":"10","author":"Nolan","year":"2017","journal-title":"IDCases"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7326\/0003-4819-79-2-153","article-title":"Spontaneous cytomegalovirus mononucleosis. Clinical and laboratory observations in nine cases","volume":"79","author":"Jordan","year":"1973","journal-title":"Ann. Intern. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/clinids\/24.1.52","article-title":"Severe cytomegalovirus infection in immunocompetent patients","volume":"24","author":"Eddleston","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1097\/IAE.0b013e318285f486","article-title":"Chronic retinal necrosis: Cytomegalovirus necrotizing retinitis associated with panretinal vasculopathy in non-HIV patients","volume":"33","author":"Schneider","year":"2013","journal-title":"Retina"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Britt, W.J. (2018). Maternal immunity and the natural history of congenital human cytomegalovirus infection. Viruses, 10.","DOI":"10.3390\/v10080405"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Dong, N., Cao, L., Zheng, D., Su, L., Lu, L., Dong, Z., Xu, M., and Xu, J. (2023). Distribution of CMV envelope glycoprotein B, H and N genotypes in infants with congenital cytomegalovirus symptomatic infection. Front. Pediatr., 11.","DOI":"10.3389\/fped.2023.1112645"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Salom\u00e8, S., Ciampa, N., Giordano, M., Raimondi, R., Capone, E., Grieco, C., Coppola, C., Capasso, L., and Raimondi, F. (2023). Ophthalmological impairment in patients with congenital cytomegalovirus infection. Front. Pediatr., 11.","DOI":"10.3389\/fped.2023.1251893"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/S1473-3099(17)30143-3","article-title":"Congenital cytomegalovirus infection in pregnancy and the neonate: Consensus recommendations for prevention, diagnosis, and therapy","volume":"17","author":"Rawlinson","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_95","first-page":"113","article-title":"Cytomegalovirus infection in patients with HIV infection","volume":"66","author":"Cheung","year":"1999","journal-title":"Mt. Sinai J. Med."},{"key":"ref_96","first-page":"CD003774","article-title":"Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients","volume":"2","author":"Hodson","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"R68","DOI":"10.1186\/cc7875","article-title":"Cytomegalovirus infection in critically ill patients: A systematic review","volume":"13","author":"Ryosuke","year":"2009","journal-title":"Crit. Care"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s10875-017-0401-y","article-title":"Advances in the Care of Primary Immunodeficiencies (PIDs): From Birth to Adulthood","volume":"37","author":"Mahlaoui","year":"2017","journal-title":"J. Clin. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Ruffner, M.A., Sullivan, K.E., and Henrickson, S.E. (2017). Recurrent and Sustained Viral Infections in Primary Immunodeficiencies. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.00665"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1172\/JCI25178","article-title":"A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection","volume":"115","author":"Lim","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1007\/s00431-022-04614-5","article-title":"Impact of cytomegalovirus infection prior to hematopoietic stem cell transplantation in children with inborn errors of immunity","volume":"181","author":"Alsina","year":"2022","journal-title":"Eur. J. Pediat."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0166-3542(96)01006-6","article-title":"Summary of the International Consensus Symposium on Advances in the Diagnosis, Treatment and Prophylaxis and Cytomegalovirus Infection","volume":"32","author":"Drew","year":"1996","journal-title":"Antiviral Res."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Heiden, D., Ford, N., Wilson, D., Rodriguez, W.R., Margolis, T., Janssens, B., Bedelu, M., Tun, N., Goemaere, E., and Saranchuk, P. (2007). Cytomegalovirus retinitis: The neglected disease of the AIDS pandemic. PLoS Med., 4.","DOI":"10.1371\/journal.pmed.0040334"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/00002030-199907090-00008","article-title":"Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy","volume":"13","author":"Deayton","year":"1999","journal-title":"AIDS"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1086\/314943","article-title":"Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy","volume":"180","author":"Drew","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1086\/319854","article-title":"Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy","volume":"183","author":"Jacobson","year":"2001","journal-title":"J. Infect. Dis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0161-6420(83)80009-8","article-title":"Acquired immune deficiency syndrome. Ocular manifestations","volume":"90","author":"Holland","year":"1983","journal-title":"Ophthalmology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0161-6420(89)32794-1","article-title":"Ocular Manifestations of Acquired Immune Deficiency Syndrome","volume":"96","author":"Jabs","year":"1989","journal-title":"Ophthalmology"},{"key":"ref_109","first-page":"623","article-title":"Ocular manifestations of HIV infection","volume":"93","author":"Jabs","year":"1995","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archopht.1996.01100140035004","article-title":"Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression","volume":"114","author":"Hoover","year":"1996","journal-title":"Arch. Ophthalmol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00006982-199313030-00016","article-title":"Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus","volume":"13","author":"Pertel","year":"1993","journal-title":"Retina"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0002-9394(14)71453-9","article-title":"Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome","volume":"115","author":"Kuppermann","year":"1993","journal-title":"Am. J. Ophthalmol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1056\/NEJM199509073331019","article-title":"Cytomegalovirus Retinitis and Low CD4+ T-Lymphocyte Counts","volume":"333","author":"Baldassano","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ophtha.2004.10.049","article-title":"Risk Factors for Mortality in Patients with AIDS in the Era of Highly Active Antiretroviral Therapy","volume":"112","author":"Jabs","year":"2005","journal-title":"Ophthalmology"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3126\/nepjoph.v11i1.25411","article-title":"Study of prevalence of ocular manifestations in HIV positive patients","volume":"11","author":"Saini","year":"2019","journal-title":"Nepal. J. Ophthalmol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2147\/OPTH.S6700","article-title":"Optimal management of cytomegalovirus retinitis in patients with AIDS","volume":"4","author":"Stewart","year":"2010","journal-title":"Clin. Ophthalmol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ajo.2011.11.014","article-title":"Incidence of Cytomegalovirus Retinitis in the Era of Highly Active Antiretroviral Therapy","volume":"153","author":"Sugar","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.ophtha.2015.02.033","article-title":"Long-term Outcomes of Cytomegalovirus Retinitis in the Era of Modern Antiretroviral Therapy","volume":"122","author":"Jabs","year":"2015","journal-title":"Ophthalmology"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1097\/00002030-200011100-00023","article-title":"Impact of highly active antiretroviral therapy on onset of Mycobacterium avium complex infection and cytomegalovirus disease in patients with AIDS","volume":"14","author":"Baril","year":"2000","journal-title":"AIDS"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/00006982-200507000-00015","article-title":"HIV-associated retinopathy in the HAART era","volume":"25","author":"Goldberg","year":"2005","journal-title":"Retina"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Tang, S., Zhao, N., Wang, L.Y., and Wen, Y. (2021). Frosted branch angiitis due to cytomegalovirus-associated unmasking immune reconstitution inflammatory syndrome: A case report and literature review. BMC Infect. Dis., 21.","DOI":"10.1186\/s12879-021-06311-4"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajo.2004.04.015","article-title":"Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection","volume":"138","author":"Kuo","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00417-014-2587-5","article-title":"Outcome of cytomegalovirus retinitis in immunocompromised patients without human immunodeficiency virus treated with intravitreal ganciclovir injection","volume":"252","author":"Agarwal","year":"2014","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_124","first-page":"9537","article-title":"Retrospective study of cytomegalovirus retinitis complicated with acquired immunodeficiency syndrome","volume":"8","author":"Huang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/bjo.80.9.849-a","article-title":"Cytomegalovirus retinitis associated with long term oral corticosteroid use","volume":"80","author":"Kulshrestha","year":"1996","journal-title":"Br. J. Ophthalmol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1001\/jamaophthalmol.2013.2860","article-title":"Clinical manifestations of cytomegalovirus-associated posterior uveitis and panuveitis in patients without human immunodeficiency virus infection","volume":"131","author":"Pathanapitoon","year":"2013","journal-title":"JAMA Ophthalmol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/ojo.ojo_28_22","article-title":"Cytomegalovirus retinitis in children post hematopoietic stem cell transplantation: Can we develop a screening protocol?","volume":"15","year":"2022","journal-title":"Oman J. Ophthalmol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/j.ophtha.2012.03.032","article-title":"Risk factors for cytomegalovirus retinitis in patients with cytomegalovirus viremia after hematopoietic stem cell transplantation","volume":"119","author":"Jeon","year":"2012","journal-title":"Ophthalmology."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/cid\/ciu201","article-title":"Frequent occurrence of cytomegalovirus retinitis during immune reconstitution warrants regular ophthalmic screening in high-risk pediatric allogeneic hematopoietic stem cell transplant recipients","volume":"58","author":"Hiwarkar","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1086\/318447","article-title":"Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation","volume":"32","author":"Crippa","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_131","first-page":"1940","article-title":"Ocular immune privilege and the Faustian dilemma: The Proctor lecture","volume":"37","author":"Streilein","year":"1996","journal-title":"Investiig. Ophthalmol. Vis. Sci."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fimmu.2016.00037","article-title":"Ocular immune privilege and transplantation","volume":"7","author":"Taylor","year":"2016","journal-title":"Front Immunol."},{"key":"ref_133","first-page":"58","article-title":"Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye","volume":"29","author":"Medawar","year":"1948","journal-title":"Br. J. Exp. Pathol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.coi.2008.01.002","article-title":"MDA5\/RIG-I and virus recognition","volume":"20","author":"Takeuchi","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"ref_135","first-page":"427","article-title":"Reticulum cell neoplasms induced in C57BL\/6 mice by cultured virus grown in stromal hematopoietic cell lines","volume":"63","author":"Haas","year":"1979","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1084\/jem.161.4.766","article-title":"Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL\/6 mice","volume":"161","author":"Mosier","year":"1985","journal-title":"J. Exp. Med."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1084\/jem.168.2.623","article-title":"CD4+ T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS)","volume":"168","author":"Yetter","year":"1988","journal-title":"J. Exp. Med."},{"key":"ref_138","first-page":"1124","article-title":"Dissemination and replication of MCMV after supraciliary inoculation in immunosuppressed BALB\/c mice","volume":"35","author":"Duan","year":"1994","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1167\/iovs.10-6904","article-title":"Lack of TNF-\u03b1 promotes Caspase-3\u2013independent apoptosis during murine cytomegalovirus retinitis","volume":"52","author":"Zhang","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1191\/1352458505ms1190oa","article-title":"The mechanism of action of methylprednisolone in the treatment of multiple sclerosis","volume":"11","author":"Sloka","year":"2005","journal-title":"Mult. Scler."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cyto.2017.05.021","article-title":"Reduced frequency of murine cytomegalovirus retinitis in C57BL\/6 mice correlates with low levels of suppressor of cytokine signaling (SOCS)1 and SOCS3 expression within the eye during corticosteroid-induced immunosuppression","volume":"97","author":"Alston","year":"2017","journal-title":"Cytokine"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"e00526-18","DOI":"10.1128\/JVI.00526-18","article-title":"Suppressor of cytokine signaling 1 (SOCS1) and SOCS3 are stimulated within the eye during experimental murine cytomegalovirus retinitis in mice with retrovirus-induced immunosuppression","volume":"92","author":"Chien","year":"2018","journal-title":"J. Virol."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Standardization of Uveitis Nomenclature (SUN) Working Group (2021). Classification Criteria for Cytomegalovirus Retinitis. Am. J. Ophthalmol., 228, 245\u2013254.","DOI":"10.1016\/j.ajo.2021.03.051"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.ophtha.2012.11.023","article-title":"Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy","volume":"120","author":"Jabs","year":"2013","journal-title":"Ophthalmology"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/s41409-020-01176-8","article-title":"Cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation under cytomegalovirus antigenemia-guided active screening","volume":"56","author":"Takehiko","year":"2021","journal-title":"Bone Marrow Transplant."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.disamonth.2014.03.007","article-title":"Ocular manifestations seen in HIV","volume":"60","author":"Becker","year":"2014","journal-title":"Dis. Mon."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000310430","article-title":"Frosted Retinal Periphlebitis in the Acquired Immunodeficiency Syndrome","volume":"207","author":"Mansour","year":"1993","journal-title":"Ophthalmologica"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10384-018-0574-9","article-title":"Spectral domain optical coherence tomography and fundus autofluorescence findings in cytomegalovirus retinitis in HIV-infected patients","volume":"62","author":"Yashiro","year":"2018","journal-title":"Jpn. J. Ophthalmol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"e16073","DOI":"10.1097\/MD.0000000000016073","article-title":"A comparative study on retinal thickness of the macular region among AIDS patients with normal ocular fundus, HIV-related microvascular retinopathy patients, and cytomegalovirus retinitis patients","volume":"98","author":"Xie","year":"2019","journal-title":"Medicine"},{"key":"ref_150","first-page":"e23002","article-title":"Post-CD19 Chimeric Antigen Receptor T-Cell Therapy Cytomegalovirus Retinitis","volume":"14","author":"Alharbi","year":"2022","journal-title":"Cureus"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/IAE.0000000000001644","article-title":"Spectral Domain Optical Coherence Tomography Findings in Macula-Involving Cytomegalovirus Retinitis","volume":"38","author":"Gupta","year":"2018","journal-title":"Retina"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/IAE.0000000000001503","article-title":"OPTICAL COHERENCE TOMOGRAPHY FINDINGS IN CYTOMEGALOVIRUS RETINITIS: A Longitudinal Study","volume":"38","author":"Invernizzi","year":"2018","journal-title":"Retina"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1097\/IAE.0000000000000218","article-title":"Spectral domain optical coherence tomography in the evaluation and management of infectious retinitis","volume":"34","author":"Kurup","year":"2014","journal-title":"Retina"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"8991","DOI":"10.1016\/S0140-6736(95)92842-1","article-title":"Natural history of untreated cytomegalovirus retinitis","volume":"346","author":"Bowen","year":"1995","journal-title":"Lancet"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"578","DOI":"10.5694\/mja14.00183","article-title":"Cytomegalovirus disease in immunocompetent adults","volume":"201","author":"Lancini","year":"2014","journal-title":"Med. J. Aust."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1001\/archopht.1989.01070020841024","article-title":"A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV Retinopathy Study Group","volume":"107","author":"Holland","year":"1989","journal-title":"Arch. Ophthalmol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"665","DOI":"10.7326\/0003-4819-115-9-665","article-title":"A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS","volume":"115","author":"Palestine","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Studies of Ocular Complications of AIDS Research Group (2001). The AIDS Clinical Trials Group. The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial. Am. J. Ophthalmol., 131, 457\u2013467.","DOI":"10.1016\/S0002-9394(01)00840-6"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4103\/ojo.OJO_190_2016","article-title":"Treatment of unilateral zone I cytomegalovirus retinitis in acute lymphoblastic leukemia with oral valganciclovir and intravitreal ganciclovir","volume":"10","author":"Tripathy","year":"2017","journal-title":"Oman J. Ophthalmol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/bjo.82.3.332b","article-title":"Sustained release intravitreal ganciclovir implant as salvage treatment in AIDS related cytomegalovirus retinitis","volume":"82","author":"Kamal","year":"1998","journal-title":"Br. J. Ophthalmol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0161-6420(96)30677-5","article-title":"Ganciclovir intraocular implant. A clinicopathologic study","volume":"103","author":"Charles","year":"1996","journal-title":"Ophthalmology"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00055735-199306000-00014","article-title":"Diagnosis and management of cytomegalovirus retinitis in AIDS","volume":"4","author":"Luckie","year":"1993","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.ophtha.2006.03.022","article-title":"Causes of Visual Acuity Loss among Patients with AIDS and Cytomegalovirus Retinitis in the Era of Highly Active Antiretroviral Therapy","volume":"113","author":"Thorne","year":"2006","journal-title":"Ophthalmology"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0161-6420(87)33454-2","article-title":"Cytomegalovirus Retinitis and Response to Therapy with Ganciclovir","volume":"94","author":"Henderly","year":"1987","journal-title":"Ophthalmology"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"971417","DOI":"10.1155\/2014\/971417","article-title":"Immune recovery uveitis: Pathogenesis, clinical symptoms, and treatment","volume":"2014","author":"Urban","year":"2014","journal-title":"Mediators Inflamm."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Yang, M., Kamoi, K., Zong, Y., Zhang, J., and Ohno-Matsui, K. (2023). Human Immunodeficiency Virus and Uveitis. Viruses, 15.","DOI":"10.3390\/v15020444"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ajo.2005.09.021","article-title":"Cytomegalovirus in aqueous humor from an eye with corneal endotheliitis","volume":"141","author":"Koizumi","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Yoo, W., Kwon, L., Eom, Y., Thng, Z., Or, C., Nguyen, Q., and Kim, S. (2024). Cytomegalovirus Corneal Endotheliitis: A Comprehensive Review. Ocul. Immunol. Inflamm., 1\u201310.","DOI":"10.1080\/09273948.2024.2320704"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/09273949709116898","article-title":"Molecular basis of ACAID","volume":"5","author":"Streilein","year":"1997","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00007890-198206000-00001","article-title":"Analysis of antibody production induced by allogeneic tumor cells inoculated into the anterior chamber of the eye","volume":"33","author":"Niederkorn","year":"1982","journal-title":"Transplantation"},{"key":"ref_171","first-page":"377","article-title":"Experimental corneal endotheliitis in rabbit","volume":"41","author":"Zheng","year":"2000","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ajo.2011.07.026","article-title":"Clinical significance of owl eye morphologic features by in vivo laser confocal microscopy in patients with cytomegalovirus corneal endotheliitis","volume":"153","author":"Kobayashi","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/APO.0000000000000522","article-title":"Clinical Findings of Specular Microscopy Images in Cytomegalovirus Corneal Endotheliitis","volume":"11","author":"Kobayashi","year":"2022","journal-title":"Asia Pac. J. Ophthalmol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/bjophthalmol-2014-306486","article-title":"Analysis of human cytomegalovirus replication in primary cultured human corneal endothelial cells","volume":"99","author":"Hosogai","year":"2015","journal-title":"Br. J. Ophthalmol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"7043","DOI":"10.1073\/pnas.1814850116","article-title":"OR14I1 is a receptor for the human cytomegalovirus pentameric complex and defines viral epithelial cell tropism","volume":"116","author":"E","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.exer.2017.06.017","article-title":"Corneal endothelial cells activate innate and acquired arm of anti-viral responses after cytomegalovirus infection","volume":"161","author":"Miyazaki","year":"2017","journal-title":"Exp. Eye Res."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1167\/iovs.04-1154","article-title":"Characterization and distribution of bone marrow-derived cells in mouse cornea","volume":"46","author":"Nakamura","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/jmv.1890470412","article-title":"Pathogenesis of ocular cytomegalovirus infection in the immunocompromised host","volume":"47","author":"Hayashi","year":"1995","journal-title":"J. Med. Virol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ajo.2006.11.026","article-title":"Demonstration of \u201cowl\u2019s eye\u201d morphology by confocal microscopy in a patient with presumed cytomegalovirus corneal endotheliitis","volume":"143","author":"Shiraishi","year":"2007","journal-title":"Am. J. Ophthalmol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/09273940701486795","article-title":"A case of hypertensive keratouveitis with endotheliitis associated with cytomegalovirus","volume":"15","author":"Yamauchi","year":"2007","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ophtha.2009.06.059","article-title":"Prevalence and Features of Keratitis with Quantitative Polymerase Chain Reaction Positive for Cytomegalovirus","volume":"117","author":"Kandori","year":"2010","journal-title":"Ophthalmology"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1136\/bjo.2008.156422","article-title":"A significant association of viral loads with corneal endothelial cell damage in cytomegalovirus anterior uveitis","volume":"94","author":"Miyanaga","year":"2010","journal-title":"Br. J. Ophthalmol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s10384-012-0189-5","article-title":"Mapping owl\u2019s eye cells of patients with cytomegalovirus corneal endotheliitis using in vivo laser confocal microscopy","volume":"57","author":"Yokogawa","year":"2013","journal-title":"Jpn. J. Ophthalmol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/ICO.0000000000001103","article-title":"Clinical Findings of Anterior Segment Spectral Domain Optical Coherence Tomography Images in Cytomegalovirus Corneal Endotheliitis","volume":"36","author":"Kobayashi","year":"2017","journal-title":"Cornea"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajo.2007.12.015","article-title":"Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients","volume":"145","author":"Chee","year":"2008","journal-title":"Am. J. Ophthalmol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1136\/bjophthalmol-2020-317044","article-title":"Efficacy and safety of oral valganciclovir in cytomegalovirus anterior uveitis with uncontrolled intraocular pressure","volume":"105","author":"Wong","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.ajo.2014.08.007","article-title":"Clinical outcomes in cytomegalovirus-positive Posner-Schlossman syndrome patients treated with topical ganciclovir therapy","volume":"158","author":"Su","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.ophtha.2012.07.024","article-title":"Ganciclovir gel for cytomegalovirus keratouveitis","volume":"119","author":"Welch","year":"2012","journal-title":"Ophthalmology"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/bjophthalmol-2015-308238","article-title":"The effect of topical application of 0.15% ganciclovir gel on cytomegalovirus corneal endotheliitis","volume":"101","author":"Koizumi","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.sjopt.2011.10.001","article-title":"Cytomegalovirus-related corneal endotheliitis: A review article","volume":"27","author":"Alfawaz","year":"2013","journal-title":"Saudi J. Ophthalmol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10792-007-9090-5","article-title":"Kinetics of aqueous flare, intraocular pressure and virus-DNA copies in a patient with cytomegalovirus iridocyclitis without retinitis","volume":"27","author":"Kawaguchi","year":"2007","journal-title":"Int. Ophthalmol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.ophtha.2006.09.035","article-title":"Cytomegalovirus as a Cause of Anterior Uveitis in Immunocompetent Patients","volume":"114","author":"Los","year":"2007","journal-title":"Ophthalmology"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/archopht.1948.00900020525007","article-title":"Syndrome of unilateral recurrent attacks of glaucoma with cyclitic symptoms","volume":"39","author":"Posner","year":"1948","journal-title":"Arch. Ophthalmol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00165685","article-title":"Clinical analysis of Fuchs\u2019 heterochromic cyclitis","volume":"78","author":"Baarsma","year":"1991","journal-title":"Doc. Ophthalmol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1869-5760-3-55","article-title":"Cytomegalovirus anterior uveitis in immunocompetent individuals following topical prostaglandin analogues","volume":"3","author":"Babu","year":"2013","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/eye.2011.327","article-title":"Cytomegalovirus and the eye","volume":"26","author":"Carmichael","year":"2012","journal-title":"Eye"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nri.2016.38","article-title":"T cell responses to cytomegalovirus","volume":"16","author":"Klenerman","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.immunol.20.100201.131730","article-title":"Lymphocyte-mediated cytotoxicity","volume":"20","author":"Russel","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"ref_199","first-page":"259","article-title":"Molecular mechanisms of lymphocyte-mediated cytotoxicity","volume":"2","author":"Fan","year":"2005","journal-title":"Cell Mol. Immunol."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Voigt, V., Andoniou, C.E., Schuster, I.S., Oszmiana, A., Ong, M.L., Fleming, P., Forrester, J.V., and Degli-Esposti, M.A. (2018). Cytomegalovirus establishes a latent reservoir and triggers long-lasting inflammation in the eye. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1007040"},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Zhang, J., Kamoi, K., Zong, Y., Yang, M., and Ohno-Matsui, K. (2023). Cytomegalovirus Anterior Uveitis: Clinical Manifestations, Diagnosis, Treatment, and Immunological Mechanisms. Viruses, 15.","DOI":"10.3390\/v15010185"},{"key":"ref_202","first-page":"2861","article-title":"Cell adhesion molecule expression in cultured human iris endothelial cells","volume":"42","author":"Silverman","year":"2001","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/exer.1998.0517","article-title":"The mRNA expression of cytokines and their receptors in cultured iris pigment epithelial cells: A comparison with retinal pigment epithelial cells","volume":"67","author":"Kociok","year":"1998","journal-title":"Exp. Eye Res."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1128\/JVI.00109-15","article-title":"A Role for 3-O-Sulfated Heparan Sulfate in Promoting Human Cytomegalovirus Infection in Human Iris Cells. ASM Journals","volume":"89","author":"Baldwin","year":"2015","journal-title":"J. Virol."},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Chang, K., Majmudar, H., Tandon, R., Volin, M.V., and Tiwari, V. (2022). Induction of Filopodia During Cytomegalovirus Entry Into Human Iris Stromal Cells. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.834927"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/09273948.2017.1394471","article-title":"Clinical Features of CMV-Associated Anterior Uveitis","volume":"26","author":"Chan","year":"2018","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"43349","DOI":"10.1038\/srep43349","article-title":"Enhanced cytomegalovirus infection in human trabecular meshwork cells and its implication in glaucoma pathogenesis","volume":"7","author":"Choi","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000309939","article-title":"Cytomegalovirus panuveitis with infection of corneo-trabecular endothelium in AIDS","volume":"197","author":"Daicker","year":"1988","journal-title":"Ophthalmologica"},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Griessl, M., Renzaho, A., Freitag, K., Seckert, C.K., Reddehase, M.J., and Lemmermann, N.A.W. (2021). Stochastic Episodes of Latent Cytomegalovirus Transcription Drive CD8 T-Cell \u201cMemory Inflation\u201d and Avoid Immune Evasion. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.668885"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/cmi.2014.75","article-title":"The immunology of human cytomegalovirus latency: Could latent infection be cleared by novel immunotherapeutic strategies?","volume":"12","author":"Wills","year":"2015","journal-title":"Cell. Mol. Immunol."},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Jackson, S.E., Chen, K.C., Groves, I.J., Sedikides, G.X., Gandhi, A., Houldcroft, C.J., Poole, E.L., Montanuy, I., Mason, G.M., and Okecha, G. (2021). Latent Cytomegalovirus-Driven Recruitment of Activated CD4+ T Cells Promotes Virus Reactivation. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.657945"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/cxo.12811","article-title":"Overcoming diagnostic and treatment challenges in uveitic glaucoma","volume":"102","author":"Sherman","year":"2019","journal-title":"Clin. Exp. Optom."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1167\/iovs.62.13.22","article-title":"Establishing an animal model of cytomegalovirus keratouveitis in rats: Broad infection of anterior segment tissue by cytomegalovirus","volume":"62","author":"Zhang","year":"2021","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s00417-014-2782-4","article-title":"Cytomegalovirus anterior uveitis: Long-term follow-up of immunocompetent patients","volume":"252","author":"Accorinti","year":"2014","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0039-6257(97)00006-4","article-title":"Glaucoma associated with uveitis","volume":"41","author":"Moorthy","year":"1997","journal-title":"Surv. Ophthalmol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/bs.pbr.2015.06.008","article-title":"Uveitis and glaucoma: New insights in the pathogenesis and treatment","volume":"221","author":"Sng","year":"2015","journal-title":"Prog. Brain Res."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"14950","DOI":"10.1038\/s41598-021-94391-2","article-title":"Role of MCP-1 and IL-8 in viral anterior uveitis, and contractility and fibrogenic activity of trabecular meshwork cells","volume":"11","author":"Lee","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.ophtha.2013.02.020","article-title":"Use of a Comprehensive Polymerase Chain Reaction System for Diagnosis of Ocular Infectious Diseases","volume":"120","author":"Sugita","year":"2013","journal-title":"Ophthalmology"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/bjo.2005.086546","article-title":"Diagnosis and treatment of cytomegalovirus iridocyclitis without retinal necrosis","volume":"90","author":"Rozenberg","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ajo.2021.03.020","article-title":"Distinguishing Features of Anterior Uveitis Caused by Herpes Simplex Virus, Varicella-Zoster Virus, and Cytomegalovirus","volume":"227","author":"Terada","year":"2021","journal-title":"Am. J. Ophthalmol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10384-014-0340-6","article-title":"Comparison of the ocular characteristics of anterior uveitis caused by herpes simplex virus, varicella-zoster virus, and cytomegalovirus","volume":"58","author":"Takase","year":"2014","journal-title":"Jpn. J. Ophthalmol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0161-6420(02)00961-2","article-title":"Cytomegalovirus as a cause of anterior uveitis with sectoral iris atrophy","volume":"109","author":"Markomichelakis","year":"2002","journal-title":"Ophthalmology"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.antiviral.2006.05.002","article-title":"Antiviral drugs for cytomegalovirus diseases","volume":"71","author":"Biron","year":"2006","journal-title":"Antiviral Res."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s004170000193","article-title":"Ganciclovir for the treatment of anterior uveitis","volume":"238","author":"Mietz","year":"2000","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00417-013-2535-9","article-title":"Long-term oral therapy with valganciclovir in patients with Posner-Schlossman syndrome","volume":"252","author":"Sobolewska","year":"2014","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jop.2016.0138","article-title":"Topical Ganciclovir in Cytomegalovirus Anterior Uveitis","volume":"33","author":"Antoun","year":"2017","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Waduthantri, S., Zhou, L., and Chee, S.P. (2018). Intra-cameral level of ganciclovir gel, 0.15% following topical application for cytomegalovirus anterior segment infection: A pilot study. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0191850"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1136\/bjo.2009.167767","article-title":"Cytomegalovirus anterior uveitis: Outcome of treatment","volume":"94","author":"Chee","year":"2010","journal-title":"Br. J. Ophthalmol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ajo.2018.07.021","article-title":"Cytomegalovirus Anterior Uveitis: Clinical Characteristics and Long-term Outcomes in a French Series","volume":"194","author":"Touhami","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00417-009-1195-2","article-title":"Intravitreal loading injection of ganciclovir with or without adjunctive oral valganciclovir for cytomegalovirus anterior uveitis","volume":"248","author":"Hwang","year":"2010","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/7\/1110\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:13:14Z","timestamp":1760109194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/7\/1110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,11]]},"references-count":230,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["v16071110"],"URL":"https:\/\/doi.org\/10.3390\/v16071110","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,11]]}}}